药物别称in vivo target-primed reverse transcription genome editing product consisting of two chemically modified RNA drug substances: a messenger RNA, and a template guide RNA formulated in a lipid nanoparticle delivery vehicle comprised of 4 lipids to target the pathogenic PiZ allele in the SERPINA1 geneTSRA-196
